secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-05-18T20:13:58+00:00
Accession:  0000064803-26-000082
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CVS shareholders approve 2026 incentive plan, re-elect directors at annual meeting
--------------------------------------------------------------------------------

- 13 directors elected; all management proposals passed including 2026 ICP approval.
- 2026 Incentive Compensation Plan replaces expiring 2017 plan; effective for awards after May 14, 2026.
- Advisory say-on-pay passed with ~94% of votes cast (excluding broker non-votes).
- Ernst & Young ratified as independent auditor for 2026 with 1.12B votes for.
- Stockholder proposal to reduce written consent threshold failed with ~40% support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000082/0000064803-26-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000082/cvs-20260514.htm
  HTML page:      https://secwatch.observer/filing/0000064803-26-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer